NCT05133323: A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
- State
- Completed
- Phase
- Phase 2
- People
- 237 taking part
- Started
- 11 Nov 2021
- Primary completion
- 19 Jan 2023
- Arms
- Lu AG09222 High Dose, Lu AG09222 Low Dose
- Results
- Posted on the registry
- 11 Nov 2021: Trial started
- 24 Nov 2021: Trial registered
- 16 Mar 2023: Trial completed
- 8 Feb 2024: Trial results posted